Online ISSN: 2515-8260

Homeopathic Clinical Drug Proving Trial on Rhodiola Rosea

Main Article Content

Jvn Dr. Panckaj Garg,Jvn Dr. M. P. Sharma Jvn. Dr. Rakesh Sharma Jvn Dr. Anil Kumar Vangani Jvn Dr. Pushpa Kumawa


Brief Summary: The main aim of the study is to assess whether Rhodiola rosea in the potency C 1-4 nitites more characteristic homeopathic symptoms during proving after three days upto one week, compared to a placebo in Hypertensive and Anxiety/ Depression prone volunteers. Secondary aims are to develop and to test a qualitative analysis methodology on which to base a definition for drug-specific (characteristic) symptoms and to compile a profile of characteristic homeopathic proving symptoms of the drug being trialed for therapeutic purposes. This study protocol adapts the traditional homeopathic drug proving methodology to a modern clinical trial design.

Article Details